Fellowship · Los Angeles, CA
Sponsored by UCLA David Geffen School of Medicine/UCLA Medical Center
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
JAMA oncology · 2022 · 1,677 citations · Kevin Ikuta
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.
The New England journal of medicine · 2025 · 227 citations · Jesse L. Clark
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.
JAMA · 2025 · 210 citations · Raphael J. Landovitz
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
JAMA · 2023 · 462 citations · Raphael J. Landovitz
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026.
Critical care medicine · 2026 · 81 citations · Nicholas Mohr
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
The New England journal of medicine · 2023 · 451 citations · Judith S. Currier
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
The New England journal of medicine · 2021 · 759 citations · Raphael J. Landovitz
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 167 citations · Rick Fairhurst